AMTN

amelotin

Basic information

Region (hg38): 4:70518568-70532743

Links

ENSG00000187689NCBI:401138OMIM:610912HGNC:33188Uniprot:Q6UX39AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • amelogenesis imperfecta, type 3A (Supportive), mode of inheritance: AD
  • amelogenesis imperfecta type 3B (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Amelogenesis imperfecta, type IIIBADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingDental27412008

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AMTN gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMTN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
8
clinvar
3
clinvar
3
clinvar
14
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 8 3 4

Variants in AMTN

This is a list of pathogenic ClinVar variants found in the AMTN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-70518771-C-T AMTN-related disorder Benign (Mar 21, 2019)3059340
4-70518788-C-T not specified Likely benign (May 30, 2022)2357282
4-70518820-C-T AMTN-related disorder Benign (Mar 21, 2019)3058967
4-70520179-AGGCCGGCTGTGCAGGCCACAGCAGATTGCTAATAGACAATGAGAGCAGCTAGAGAGCTAGTGGGGCAGGGCAGCAGGGAGGCGACACTGAAATGTCTATTCAGTATGGAAACAATACCAAATGAAACATCACGACACATAGACAAGGTATTTTTTATTATTTGTAAATGAATGTATTGAGTTAGCATAAAGGTAAAAAGAGTGAATCCATTTGCAAATGTGGACACATACAACAGCCTAGCAATTATTTTCAGTAGATCAAAATTTTGAGGATAGGTACCAGATGGAAAACACAATGAGTAGAAGAAATAAATACAAGACAAATCAAATTTACAGAAAGTGAAGGCTCTAGAAGAAAACAAGATTTTATTCCTTCAACAACTATTTATTGAGTTCTTACTATATGCCAGACATGGATTTATCTTTTTGAGATGGATCATTGAATAAACCACAGTGAAGTCTATATTTTAGCAAGGAAATAAATGATAAATGGTGAGCAGTCTAAATCAGTAGGTCACATGACAGGTTAGGAGATAGTGAGCACTATGAAAAAAAGATCCCAGAGCAGGGTGAGATGGAGCAGGCTGGTGGTGCACAGTGGAGAAGGGGCAGGCTGCATGTTCAGGACAGCAGTCAGGTTTGGCCTCAATAAGAGGGAAATTCAAGTAAAGAAACAGGTGAGAGAGTAAAGCCAATGTTCAGGGAAAGAACATTCCAGACAGAGGGAACAGGTGGAGGTGAAATTCTGAAGCAGGAATGGACTTTACCTGTTGCAGAAACAGCAAAATGGCTGGATGGCCAGAGCAGAGTGAGGGAGGGGAAATGAGGTAGGAAAGATCAGAGAGCTACTGGGGGCCCAGAGCCCTGTAGACCACTGTGGGGTCTCTGGCTTTTACTCTGAGTGAAATTGACAGTCGTTGGCCAGGCACGGTGGCTAACGCCCGTAATCCCAACACTTTGGGGGCCAAGGCAGGCGGATCACTTGAGATCAGGAGTTCAAGACCAGCCTGACCAATATGGTGAAACACCGTCCCTACTAAAAATACAAAAAATTAGCTGGACGTGGTGGTGTGCACCGGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAAAATCATTTGAACCTGGGAGGTGGAGGTTGCAGTGAGCCAAGATCACTCCATTGCACTCCAATCTGGACAGCAGAACAAGACTCCACTTAAAAAAAAAAAAAAAAGAAGAAGAAAAGAAAGAAAAGAAAAAAAATTGGTAGTCATTGCAGAGACTGAGAAAAGAAGCAACAAGATTAGACCATCATTTTCACAGGGTCACTCTGGCTACTATACTAACAATAGATTGTGGGAGATGAAAAGACTTACTTACAAAATTTATATATATTATATATATGTATTTTATGTATATATATGTATATATAATCTTAAAGCTGAAAGGGACCTCCTAGAACAGATAATACCAACCTCTCTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGTGAGACAGAGTCTCACTCTGCAACCTCTGGCTCCCGGGTTCAAGTGATTCTCCTTCCTCAACCTCCCGAGTAGCTGGGACTATAAGCGTGCACCACCATGCTCAGCTAATTTTTATATTTTTAGTAAAGACAGAGTTTCATCATGTTAGCCAGGCTGGTCCTGAACTCCTGACCTCAAGTGGTCCGCCCGCCTTGGCCTCCCAAAGTGCTGGGATTACACGGTGGCATGAGCCACCGTGCCCAGCCCCAACCTCTCCTCATAACTAAGGGGGAAATTCCAGCGTGAAACCAAAACTGCTCCAGGGTAACCTTAGATGACTCAAGGGCTGGTGCAGAGCCAGAGGGCCACACCCCTGTGCCTTCCAGGATGCCTCCAGGAGCAAAAGCAGATTTGGTCAACCTGGCAAAAGAGAAGTTTTTTTTTCGGAGACTAAGAGCACTTAGAGGGATCTAGCACTGGCTCTGCTGCTCACCATGTCACCTTGGGCAAGTTACTGTAAGCATCAGTTGCCTCATCTATTAGAAAAAAATAATACAACTAGACCAAATGTGTAGGAGGAATATTTTCATATCTAAAAATTCAGTGATTTTTAATACACTAATAAAATATCCAGGCCAGGAAGAAAAACTGAACTTCTGTTACAAGACCGATGTGGCAGGCATGGCAATAGTGGGAAGCTTCATGAAAAGGTAGTAAGAATGACGGCAGCTTACCTCAAGCCCTGAGAAAAAGCAAATGTGCACAGAGCTAAGGTACAGATTATATATTCATGTCCTGGCAAAAGAGAAAGAAAGGTACAGAAAAGAAATGGGAGCCAGGAACCACCACAAGACATCCCATCTGCTTGGGTTCATCCCAGCCCCCTTCCCTCCACACCATCCCACCCCTCCTGGGCTGGCATTTTTCCACTCTACATGTCCTACCATGCACATAATGTTTCAGGGAATCAAACTCCTCTAAAATACACAAAGCCTAAAAGATAGACATGTTTGCATTGGTGGCAACCTGGATATAAATGGACACAAAATCTTAAACACATTCCTGCCTCATCAAATATGTATTTGTTTTCACAAAAGCAGCTCAAACCTGCTTTGGGACTCCCTCCCACAAAACTGGCTCCGGATCAGGGAACACTACCAAACCAACAGCAGTCAAATCAGGTAAGAGTCCTACAATATGGAACATGTACAAACCGGTAAAGAAAATACGGAACATGTACAAACCGGTAAAGAAAACACGTTAAGACTGGTAGGTTTAAAATCAAAATTTACATGAAGACTGTACAAGACTGAACAAGAGAGAGGCTTTTCGTTTGGGAGTGGGGAAAAGAACCGATATAATTTTCTGAAAAATTTGAATAGGAAAAGTAAAGTACTCTAATTCTTTTTCCTTTTATCTGAATAATAATTTGGTTTAGCAGTGAAATCTAGTCAACTTTGAAAAGGAATACCTACGTCTGTTTACAAAGCTTGGTCATCTATGGACTTGAGGTACTGTGGCATTATCATATGCAGTATTTGCCAGCAATAGCAGGGAATCAGAGATGATCTATAAAAAATAACTGCAGATTTCCTCCTGGCTTTGTAAAGTTTCATTGTTGCTGATGTGTTGATGTGTTGCTGTTCAATCTGTTTCTTCAAAGCGTATTTAAATACTTTTGAAAACTGCATTATCTTTTGGCTACTGCCCTCCCTCCCACTTCAACTCTTCCTCTGCTGTGAAGGGCCATGGCTTACCTACTTCTACATTTTGTGAAGTAATATAATCAGATAACACTAGAGTCTAAAGTCTTCTCCTCAGTCAACAGAACACTCAAGTCAAGACCCATTCTCCCCGCTTAAGGAATCTGAATCTTATACAATTTGGGAACCTTCTTTAAGAAAAAGAATACAAAATTCGATATGTAAAATTAAGTACTGAAATAAATATTTATAATGTGATAAGAAATAACAGTAAATCACAAATTTTCTTAAGCTGATAAGTACCGTAAGCTTGAGACATTGCTAGGGCACCTCCCAGGGCCACAAAGGGAGCAATGCTAGTGAGAGGCCCCGAGGCTTCATCTTTATTTACCTTCATGGTAAACCCACCTCTGACAGGACTGTCAATTACATGAGGATATCCACCACTGACAGAGTAAGGGAAGCAGACAACCTCTTGTCTCATACATCACTTTCAATCCCCTGCAGGTCTTTCCTTCTTTAAGTCTGATACCATTAACACAGATGCTCACACTGGGGCCAGATCTGCATCTGGTAAGTGATTGTTTATATTATTTTAATACCCATTGTGAAATAAATATAATGCCTAATATTACAGTGGGGGGAGCATGTATATGGGTGCGTATATCCACAAATGAAAACACACATATACTTATTCACATAGATAAGTTGAAAGAGAGGAGAGAAGAGTCCAAGAGAGTTGGACATCATTAAACGTTTTTCTTAGCAAGAGAGTCTCTAAACAAATTAATCTAATTCTTTCCTTCTCCAGTTTCTCTAACCTCTTCTCCTCCTCTCTCCATTCCTCCACCATACCTTCTTTAATGCCCCTACAGCATCCACACATCCACATAAACACTATCACTGCTATTATCACCCACAATGACAGGAGCAAACTGGAAGAGACAAAGATCTTCAGTGTCTTCTTATAGAATATCTGTATAGATCTTCAGCCCTCTCATAGAATATCTGTGTAATCTGTTTGAGAAGAACAATAAGTTTCTTTCCTGAGTTAAAGTGGATTTTTTTAGTGGTCAAATTTAAATATAGCTCATGTTCCAGACAAAATATGTAGTCTGAACCTCATAATTTTCACGCATAACCTAGAGGAGTTAATTTCTTAATTGTAAAAAAGCTATCAGAAAATTTTCAGGAAGAATTGCTCTTGTAGCCAAAAGGGGAAAGCAAAGATAAAAATAAATCACTTAAGTAATTCTCAAACAGAATAGGTTAAATGCCAAAGAAAAACTTAACAGGGGAAAAGTTAGCAATAGCCCTTGTAGTCGTACAAGCAGACTAAATAAGTCTTTAAATTTCATCTTTGTGTCTAAGTATACATGCAATAGAACACTATGTATTTACATAGCAACTCCTTCCTTTAAATATATTTTACGTTTAGTAAAAACATTTTAGTTTCCTAAATGTCCAAACTGAAAAAAAATACAATGAAAGTCTTCTTCCTTGCCCTACAGTTAAATCCTGCTGCAGGAATGACACCTGGTACCCAGACCCACCCATTGACCCTGGGAGGGTTGAATGTACAACAGCAACTGCACCCACATGTAAGTTGAACAGCTGGACCTTAGTTTTAACATTAGAGAGCATTTTCTCTCAGGTGAAAGCCTACAGTAGAAATTTTTTAAAGCTTCTTGAAAATTTTGCCCAGATTATTAACTGACGAATGTTCTGCTGAACATAGACCAGTATTTGACAATCTGGTTCTTAATGAAAATTCATAAACATACCCAGAGAACTGACCATGCTACCTCACAACTTCTCTAGAATATATGTTTAATGGACAGGAAACCTTGAAAAGTTGGGGAAGATTGAAAAGTGAAAAATACATGGGGGGAAGTTGAGAGATCCCAGGATTTTTCTCTAGCATATTGTTTTCTCTTGAAGACTTTCTTGGTGACCAAGATCATCTCAAAGAAAAATTAAGAGGTGGATAAAGTTTATCTTCAGCAAATCTAATTGTCCCATTTTTGCGCCTTTTCATTCCCCCTTGAAAGTCCCCAAGGACTTTTCAGTATTTACCACCTCCCACTATCACTTGCTTTCAAAAAAACGAAACCTGAAAATCCTCTTACACTAAGATATAAACGACATACTTTAGGCATCACCTGTTTTTGAAGTGTTTGCATTTTAACATTGAACAAATTCCAAATTTTTACCTTATCGAAACTTTTCTAAATAGTGTAATAGGCTCCAGAGGGGCTGGGTGCAGTGGCCCACGCTGTAATCCCAGCACTTTGGAAGGCCAAGGCAGGAGGATCACTTGAGCCCAGGCATTTGAGACCAGCCTGGGCAACATAGTGAGACTTATCTCTACAAAAAATAAAATAAAATAAATAGCCAGGCGTGGTGGGGCTCACCTATAGTCCCAAGTACTCGGGAGGCTGAGGTGGGAGGATCACTTGAGCAAGGGAGGTCAAGGCTGCAGTGAGCAGCGATTGTGTCACTGCACTCCATCCTGGGTGATGAAGGGGGATTCTGTCTCAAAAAAAAAGAGAAGGAAAAGAAAGTCTCTGGAGGAAAATACAATAATCCTTTTACAGCAAGACTAAGTTGTTTGTAGATAACTTATTCTCCCCAACATGTGACCTCGGCCCCCATTATCCAACATAATGGTCTAATTTTTTGTAGAAGCATTTATTATTGTGTAAGTAATATATGTTAATTATAAAGAATTTAGGAAATGTAAATTTTCTAAAATTTACATATAAGCAAAAAATAAAATAAAATTCACTTGGAATCTCATTAGCCATAATCAAACACTGTCAACATTCTAGAGTATGTCCTTCCAGTCTTTTTTCTATACACATAAGTACATTTTTAAATAAAATGTTTTTGCTATAATGTTTTGTAACATGCTTTTTTCCACAAATATATTTTGAATAGTTTTCATGTTTTAAAATATTCACTCACAATGTTGTTTTTAATGACTGCTTAGTAGTCCATGGTATACTAAATTACTTATTATGAAAATTTGGGGGTTTTTCCAAAGTCTTTGCTTCTATAAACAATGCTACAGTGAGCATCCTTGTGACTAAGTCTATGATATTCCAATGACTATTTCCTTTGGACCAACTCTTAGGAACACAATTTCTGGAGCCAAAGACACACAAAGTATCTTGATAATAAAATTTTTGATAATAAAAGTGAACCTCTGTAAAAGATTTAAGATGCAAATAAAAAGAGACTCTCCATAACAGGTGATCATACTATAATCTACATACTGATTGCCCAGCTTCAGTCTCCATTGTTGCCCTCCTCTAACCTTGAAGGTAGACTTACTGCATCTTCATGTTCCCCAGAGAGTACCCTCCTAAGTCAAGGCATTAGTGGAGCCTGGAGATGTTACAAAAGTTTCAGTACAGAGAGTTTCACGTTGTACACTCTCTGTGCAATATTATAAATCAGTCCCCATTTGCTGTGGGAATTCTTCAATGTCTCTAGAATGTGCTACCACCAAGGGTTCCCATACCTGACCTTCCCCTGGGCAGCTCTAGTCCCTCCAACCCTGCCTTTCCCTGTGCAGAGTGGCTTATTATCTCTGCCACAACCTGGACACCTACTGGTGGCTCGCATTTATCAAAGAAAAATGAACCATGCTTGTGAACTCTAGAACCACACAATTTCTGGTTAAATGTCAGCTCTACACTTATTACTTATATGATGTTGGCCAAGTTACTTAACCACTCTGTGGCTCATTTTGCTCAAAATTTAAAATGGGCATTAAAGTAGAACCTTCCTCTACAGCTGTTGCAAAGATCAAATGAGTAAATATATGGAAAACACTTAAAACAATGCCTACCACATAGTAAACATGCGATGTGTTATTACGATTTCAAATAATTTCTCTACCGACAACTAAGAAAAAAGTCCTCTTTATTGTTATATTGGTGAACAATTAGAGTACCTTTCATTACAGTTTTTACTTAGACATCTATGGTTTCCTCTTTTTATCTTTTTGTTCTTTCCACTCCAACTTTCCATTAAAAAAGAAATTTCCATTTCATTTTCTCTTAAATCAAAAATATACCAACCACTTTCCCATTGCCACGTGAAGGCTAGTTGGGTTTTTTGTTCTTGTTTTGTTGTCCTTTTTTGTCAGTAGAGAAGGACCTGATTGTGAGTAAGGCTTTTTAATAAATGTACGTAATTTTTCCTTGTTGGCATTCCATAGTTCCATAATTCCTGCACCAACTGTCTTGGGAAACAATAGTTAACAGTCTATTTCATAAGACTTTCAAATCTTCTGGTTTGGTAATTATGAAATTAAGAGTCCCATTTTGATTACTTTCCTGACACTTTGAATTTTCTATAGAAATAAGAATAAATTTTTAAAACCTTAGCTTTCTTTGACAAACTTCTGGCCGGTTCTCAAAGTAGCAGAGTATGGGAGAATGCCAACACCTCACTCGAATCTTTTTCATCTTTTTGTGAACTAAATTTATAATATTTAGTTTGTTATCAGTGACCCTTGAATTATTTCTCGCCTAGTACTAAGAGCTATACCAATGCCAGGGGTTACTGAGCAATATTCCCTATAATTGCTTTATTTTAACAGCAAGATGTCCAGACAACTATTGCAAGACTAAGTATATATACCTCAAGAAATCTTCACATTTGAAAATACCCATCGCGTGTTTTAATGTGTCTTCTGAGATGCCATTTGAAAGAAATCTGTACATTTTAACATTATTGTTACTTGAAATAATTTTCAGTTTGGAGACTTCTTGAGAACAATTTTTTTTTGTTGTTTATCCAGTTTACTAACTTCTATCTTCTAAATGTGCTATCTTGAACTGGTTTCTAAATCTCTTGGGACTAATATTCTTTTTACAAATTGGAAAAGTTCCAAACTCCCATCCAGATCTATGAATTTATATCTATGATTATAGATAATACATTAGTAATAAATATCTGTTTAACAGATACTATATCCTTTTAAGAAGATATCAATGGCCGGGCGAGGTGGCTCATGCCTGTAATCCAAGAGCTTTGGAAGGCTGAGGCAGGCAGATCACAATGTCAGGAGTTTGAGACCAGCCTGACCAACATGGTGAAACCCCGTCTCTACTAAAAATATAAAAAATTAACTGGGCATAGTAGCAGGCAACTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCACTTGAACCCAGGAGGCAGAGGTTGCAGTGAGCCAAGACCATGCCACTGCACTCCAGCCTGGGCAACAGAGCAAGACTCCATCTCCAAAAAAAGATATCAGTATTTATACCATCTTCCAGAGCTTACTTTTGAAAGAGTTTTTCTCTCATTTTTTCAGGTGTTACCAATTTTTGTCACACAACTTGGAGCCCAGGTAAAAATTATGCTTAATATTGTCTTGATTTTAAATCACCTTGCTGTGAAAGGTGATTTTCTTTCCTCAATTCACTAGATAGTTGTGAGGTTTCCAAT-CTCA Amelogenesis imperfecta type 3B Pathogenic (Aug 05, 2017)431413
4-70522773-G-A not specified Uncertain significance (Dec 13, 2021)2351379
4-70523877-T-C AMTN-related disorder Benign (Mar 03, 2020)3042027
4-70524865-C-T AMTN-related disorder Benign (Sep 27, 2019)3041073
4-70524900-G-A not specified Uncertain significance (May 24, 2024)3293517
4-70524911-C-A not specified Uncertain significance (Feb 03, 2022)2275519
4-70524918-T-G not specified Uncertain significance (Mar 31, 2023)2531681
4-70524930-G-A AMTN-related disorder Likely benign (Oct 15, 2019)3046216
4-70524955-C-A not specified Likely benign (Jun 01, 2023)2555226
4-70524959-C-T not specified Uncertain significance (Apr 07, 2023)2570356
4-70531144-G-A not specified Uncertain significance (Dec 06, 2022)2333069
4-70531211-G-T AMTN-related disorder Benign (Dec 31, 2019)780464
4-70531243-G-T not specified Uncertain significance (Jun 03, 2022)2219597
4-70531259-G-A not specified Uncertain significance (Apr 07, 2022)2394449
4-70531262-C-A not specified Uncertain significance (Apr 17, 2023)2537214

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AMTNprotein_codingprotein_codingENST00000339336 814203
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.13e-110.02151257140161257300.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.380991100.8980.000005391301
Missense in Polyphen2020.6570.96818260
Synonymous-0.4894843.91.090.00000226453
Loss of Function-0.7041411.41.224.85e-7138

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001210.000121
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00007970.0000791
Middle Eastern0.0001090.000109
South Asian0.00006540.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Is a promoter of calcium phosphate mineralization, playing a critical role in the formation of the compact, mineralized, aprismatic enamel surface layer during the maturation stage of amelogenesis. {ECO:0000269|PubMed:25407797}.;
Disease
DISEASE: Amelogenesis imperfecta 3B (AI3B) [MIM:617607]: An autosomal dominant form of amelogenesis imperfecta, a defect of enamel formation. AI3B is characterized by hypomineralized enamel that has reduced tickness and exhibits structural defects. {ECO:0000269|PubMed:27412008}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) (Consensus)

Recessive Scores

pRec
0.0547

Intolerance Scores

loftool
0.763
rvis_EVS
1.3
rvis_percentile_EVS
93.95

Haploinsufficiency Scores

pHI
0.0448
hipred
N
hipred_score
0.123
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0517

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Amtn
Phenotype
skeleton phenotype; growth/size/body region phenotype; craniofacial phenotype;

Gene ontology

Biological process
cell adhesion;biomineral tissue development;odontogenesis of dentin-containing tooth;post-translational protein modification;cellular protein metabolic process;positive regulation of biomineral tissue development;positive regulation of enamel mineralization
Cellular component
basement membrane;endoplasmic reticulum lumen;cell-cell junction;extracellular matrix
Molecular function
molecular_function;protein binding